Crystalline Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Crystalline Management's APEN Position: Q2 2023 in Review

Crystalline Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 308,646 shares — an estimated $3.03M sold.

Crystalline Management first reported a position in APEN in Q4 2022 and held it in 2 quarters. The position peaked at $3.03M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

• Crystalline Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
• Crystalline Management sold 308,646 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $3.03M.
• Crystalline Management first reported a position in Apollo Endosurgery, Inc. in Q4 2022 and held it in 2 quarters.
• Crystalline Management's Apollo Endosurgery, Inc. position peaked at $3.03M in Q1 2023.
• 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Crystalline Management's 13F filing for Q2 2023, filed 9 Aug 2023.